230 related articles for article (PubMed ID: 9058792)
1. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.
Hurtado JC; Kim YJ; Kwon BS
J Immunol; 1997 Mar; 158(6):2600-9. PubMed ID: 9058792
[TBL] [Abstract][Full Text] [Related]
2. Costimulation of CD28- T lymphocytes by 4-1BB ligand.
DeBenedette MA; Shahinian A; Mak TW; Watts TH
J Immunol; 1997 Jan; 158(2):551-9. PubMed ID: 8992967
[TBL] [Abstract][Full Text] [Related]
3. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28.
Hurtado JC; Kim SH; Pollok KE; Lee ZH; Kwon BS
J Immunol; 1995 Oct; 155(7):3360-7. PubMed ID: 7561030
[TBL] [Abstract][Full Text] [Related]
4. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
Vinay DS; Kwon BS
Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
[TBL] [Abstract][Full Text] [Related]
5. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.
Li Q; Carr A; Ito F; Teitz-Tennenbaum S; Chang AE
Cancer Res; 2003 May; 63(10):2546-52. PubMed ID: 12750278
[TBL] [Abstract][Full Text] [Related]
6. Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4.
Pollok KE; Kim SH; Kwon BS
Eur J Immunol; 1995 Feb; 25(2):488-94. PubMed ID: 7875212
[TBL] [Abstract][Full Text] [Related]
7. Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28- T cells.
Chu NR; DeBenedette MA; Stiernholm BJ; Barber BH; Watts TH
J Immunol; 1997 Apr; 158(7):3081-9. PubMed ID: 9120260
[TBL] [Abstract][Full Text] [Related]
8. 4-1BB costimulation promotes human T cell adhesion to fibronectin.
Kim YJ; Mantel PL; June CH; Kim SH; Kwon BS
Cell Immunol; 1999 Feb; 192(1):13-23. PubMed ID: 10066342
[TBL] [Abstract][Full Text] [Related]
9. Activation of c-jun N-terminal kinase by 4-1BB (CD137), a T cell co-stimulatory molecule.
Kim HH; Kwack K; Lee ZH
Mol Cells; 2000 Jun; 10(3):247-52. PubMed ID: 10901161
[TBL] [Abstract][Full Text] [Related]
10. 4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells.
Choi BK; Bae JS; Choi EM; Kang WJ; Sakaguchi S; Vinay DS; Kwon BS
J Leukoc Biol; 2004 May; 75(5):785-91. PubMed ID: 14694186
[TBL] [Abstract][Full Text] [Related]
11. Analysis of expression and function of the costimulatory molecule 4-1BB in alloimmune responses.
Tan JT; Ha J; Cho HR; Tucker-Burden C; Hendrix RC; Mittler RS; Pearson TC; Larsen CP
Transplantation; 2000 Jul; 70(1):175-83. PubMed ID: 10919597
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy.
Sica G; Chen L
Arch Immunol Ther Exp (Warsz); 1999; 47(5):275-9. PubMed ID: 10604232
[TBL] [Abstract][Full Text] [Related]
13. Role of 4-1BB in immune responses.
Vinay DS; Kwon BS
Semin Immunol; 1998 Dec; 10(6):481-9. PubMed ID: 9826581
[TBL] [Abstract][Full Text] [Related]
14. Costimulation of human CD28- T cells by 4-1BB ligand.
Bukczynski J; Wen T; Watts TH
Eur J Immunol; 2003 Feb; 33(2):446-54. PubMed ID: 12645943
[TBL] [Abstract][Full Text] [Related]
15. 4-1BB is expressed on CD45RAhiROhi transitional T cell in humans.
Garni-Wagner BA; Lee ZH; Kim YJ; Wilde C; Kang CY; Kwon BS
Cell Immunol; 1996 Apr; 169(1):91-8. PubMed ID: 8612300
[TBL] [Abstract][Full Text] [Related]
16. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB.
Cannons JL; Hoeflich KP; Woodgett JR; Watts TH
J Immunol; 1999 Sep; 163(6):2990-8. PubMed ID: 10477561
[TBL] [Abstract][Full Text] [Related]
17. Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.
Kim JA; Averbook BJ; Chambers K; Rothchild K; Kjaergaard J; Papay R; Shu S
Cancer Res; 2001 Mar; 61(5):2031-7. PubMed ID: 11280763
[TBL] [Abstract][Full Text] [Related]
18. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.
May KF; Chen L; Zheng P; Liu Y
Cancer Res; 2002 Jun; 62(12):3459-65. PubMed ID: 12067989
[TBL] [Abstract][Full Text] [Related]
19. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
Cheuk AT; Mufti GJ; Guinn BA
Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
[TBL] [Abstract][Full Text] [Related]
20. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
